Enzo Biochem, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

12 Months Ended

Jul. 31, 2017

A summary of the activity pursuant to the Company’s stock option plans for the years ended July 31, 2017, 2016, and 2015 is as follows:

	2017					2016					2015
	Options			Weighted - Average Exercise Price		Options			Weighted - Average Exercise Price		Options			Weighted - Average Exercise Price
Outstanding at beginning of year		1,808,875		$	3.43		1,358,104		$	3.04		1,155,910		$	5.03
New Grants		496,996		$	7.07		490,473		$	4.48		383,873		$	3.55
Exercised		(141,876	)	$	3.19		(33,702	)	$	2.81		—		$	—
Expired		(33,000	)	$	5.29		(6,000	)	$	3.61		(181,679	)	$	16.84
Outstanding at end of year		2,130,995		$	4.26		1,808,875		$	3.43		1,358,104		$	3.04
Exercisable at end of year		1,388,475		$	3.27		1,094,794		$	2.95		782,688		$	2.88
Weighted average fair value of options granted during year				$	2.43				$	1.58				$	1.36

The following table summarizes information for stock options outstanding at July 31, 2017:

	Options outstanding and exercisable
Range of Exercise prices	Shares		Weighted-Average Remaining Contractual Life in Years		Weighted-Average Exercise Price
$2.53 - $4.35		1,425,460		1.13	$	3.25
$4.66 - $7.07		705,535		1.35	$	6.31
		2,130,995

The following table summarizes the activity pursuant to restricted stock awards for the years ended July 31,

	2017						2016						2015
	Awards			Weighted - Average Award Price			Awards			Weighted - Average Award Price			Awards			Weighted - Average Award Price
Outstanding at beginning of year		8,501		$	4.13			21,501		$	8.84			42,502		$	5.74
Awarded		4,250		$	6.95			—		$	—			4,250		$	4.75
Vested		(5,140	)	$	(4.10	)		(11,500	)	$	(2.83	)		(19,418	)	$	(2.83	)
Forfeited		(175	)	$	(2.14	)		(1,500	)	$	(2.86	)		(5,833	)	$	(3.22	)
Outstanding (non-vested) at end of year		7,436		$	4.45			8,501		$	4.13			21,501		$	8.84
Weighted average market value of awards granted during year				$	6.95					$	—					$	4.75